Prospective cohort study of high‐volume transanal irrigation in patients with constipation and/or faecal incontinence
Colorectal Disease · 2023-08 · 25 (8) · 1658-1670
DOI: 10.1111/codi.16628 ↗At a glance
Kohortenstudie in Colorectal Disease, published online on 2023-05-31. Written by Paul F Vollebregt and 3 co-authors. Institution: Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands. Major MEDLINE topics: Constipation, Fecal Incontinence, Therapeutic Irrigation. Cited 12 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellspect.
Topics: Inkontinenz
Abstract (original language)
Aim
The aim of this work was to determine the clinical efficacy of high‐volume transanal irrigation (TAI) in patients with constipation and/or faecal incontinence using validated symptom and quality of life questionnaires.
Method
This was a prospective cohort study of 114 consecutive patients with constipation and/or faecal incontinence (Rome IV defined) who started TAI. A comprehensive questionnaire was completed at baseline and 4, 12, 26 and 52 weeks’ follow‐up. The primary objective was significant symptom reduction [≥30%; Cleveland Clinic Constipation Score (CCCS) and St Marks Incontinence Score (SMIS)] in those who continued TAI at 52 weeks. Secondary objectives were (1) continuation rates of TAI, (2) effect on quality of life (QoL) and (3) identification of predictors for continuation.
Results
A total of 59 (51.8%) patients with constipation, 26 (22.8%) with faecal incontinence and 29 (25.4%) with coexistent symptoms were included. At 52 weeks, 41 (36.0%) patients continued TAI, 63 (55.2%) stopped and 10 (8.8%) patients were lost to follow‐up. In those who continued TAI at 52 weeks ( n = 41), no reduction of constipation symptoms was observed. Median Patient Assessment of Constipation Quality of Life scores decreased on most domains, indicating QoL improvement. Reduction of faecal incontinence occurred in 5/9 (55.6%) patients with faecal incontinence and in 3/10 (30.0%) patients with coexistent symptoms. The median SMIS per‐individual decreased in patients with coexistent symptoms (2; interquartile range 0–4; p = 0.023). Median Fecal Incontinence Quality of Life scores increased in most domains, indicating improved QoL. No clinical characteristics predicted continuation.
Conclusion
One‐third ( n = 41) of patients continued TAI at 52 weeks. In those who continued TAI at 52 weeks, symptoms of faecal incontinence (SMIS) were reduced but not constipation (CCCS). QoL related to both constipation and faecal incontinence improved. No clinical characteristics predicted continuation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
- Proctos Kliniek, Bilthoven, The Netherlands.
- Department of Surgery, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
ORCID profiles: Paul F Vollebregt, Lisette Dekker
Funding
- Wellspect
Cite
APA
Vollebregt, P. F., Dekker, L., Han-Geurts, I. J. M., & Felt-Bersma, R. J. F. (2023). Prospective cohort study of high‐volume transanal irrigation in patients with constipation and/or faecal incontinence. Colorectal Disease, 25(8), 1658-1670. https://doi.org/10.1111/codi.16628
Vancouver
Vollebregt PF, Dekker L, Han-Geurts IJM, Felt-Bersma RJF. Prospective cohort study of high‐volume transanal irrigation in patients with constipation and/or faecal incontinence. Colorectal Disease. 2023;25(8):1658-1670. doi:10.1111/codi.16628
BibTeX
@article{Vollebregt2023,
author = {Vollebregt, Paul F and Dekker, Lisette and Han-Geurts, Ingrid J M and Felt-Bersma, Richelle J F},
title = {Prospective cohort study of high‐volume transanal irrigation in patients with constipation and/or faecal incontinence},
journal = {Colorectal Disease},
year = {2023},
volume = {25},
number = {8},
pages = {1658--1670},
doi = {10.1111/codi.16628}
}
EUVIMED